News
See below for the latest insights and news articles about our work.
Newsroom
Tozaro Limited raises £6m/$8.2m to accelerate development & commercialization of Smart Polymer™ affinity ligands…
The round was led by Mercia Ventures and the Midlands Engine Investment Fund II (MEIF II). Funding into 2027 will support…
Newsroom
Tozaro secures Canada-UK Research & Development funding todevelop tools for lentiviral production, in partnership…
Efficient production of lentivirus at scale for advanced therapies continues to be rate-limitingfor development of new drugs The consortium will work…
Newsroom
Tozaro announces formation of Technical Advisory Board to support commercialization of Smart Polymers in…
Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, today announced the formation of its Technical…
Newsroom
Tozaro appoints Dr. Jason Slingsby MBA as CEO to lead company strategy in cell…
Bedfordshire, UK, 1 May 2025: Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing today announced…
Newsroom
MIP Discovery rebrands as Tozaro as it completes transition to supporting cell and gene…
Tozaro’s rationally designed smart polymer affinity reagents offer novel analytics and purification solutions to enhance the development and manufacture of viral…
Newsroom
Tozaro closes £7M Series A financing to drive commercialization in cell and gene therapy…
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced…